Cross-undertaking in damages - Napp Pharmaceuticals v Sandoz Limited from ipkitten.blogspot.com What is the price of seeking an interim injunction in the Courts of England & Wales? A cross-undertaking in damages. This is designed to compensate the respondent for any damages sustained as result of an interim ...
Share via E–mail | Twitter | Facebook
Sunday Surprises from ipkitten.blogspot.com Kind reminder! The Public Consultation on the Database Directive launched by the European Commission closes on 30 August 2017. Responses to the Consultation and more details, here.
Thrilled about upcoming events!IT for Change is ... Share via E–mail | Twitter | Facebook
Judge Smith’s dissenting opinion in In re Wiechert, 370 F.2d 927 (CCPA 1967) from www.717madisonplace.com Back in 1967, Judge Smith of the CCPA dissented from the majority in the opinion of In re Wiechert, 370 F.2d 927, 152 U.S.P.Q. 247 (C.C.P.A. 1967). Judge ...
Share via E–mail | Twitter | Facebook
Conference <span class="amp">&</span> CLE Calendar from www.patentdocs.org August 8, 2017 - Patent Quality Chat webinar series (U.S. Patent and Trademark Office) - 12:00 to 1:00 pm (ET) on August 10-11, 2017 - Advanced Patent Law Seminar (Chisum Patent Academy) - Seattle, WA August ...
Share via E–mail | Twitter | Facebook
News from Abroad -- EPO Applies Doctrine of Plausibility to Small Molecule Pharmaceuticals from www.patentdocs.org In Decision T 488/16, the Boards of Appeal of the European Patent Office (BoA) have revoked EP 1 169 038, which protected the blockbuster protein tyrosine kinase (PTK) inhibitor dasatinib (Sprycel®). The only request ...
Share via E–mail | Twitter | Facebook